2013
DOI: 10.1074/jbc.m113.494989
|View full text |Cite
|
Sign up to set email alerts
|

Direct Regulation of Microtubule Dynamics by KIF17 Motor and Tail Domains

Abstract: Background: KIF17 is targeted to microtubule plus-ends by EB1 and promotes microtubule stabilization in epithelial cells. Results: KIF17 motor and tail domains have direct and distinct effects on microtubule polymerization. Conclusion: The KIF17 motor domain is sufficient to regulate microtubules, but catalytic activity is modulated by EB1 and the KIF17 tail. Significance: KIF17 can function as a direct regulator of microtubule dynamics and stability.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 46 publications
(41 reference statements)
1
18
0
Order By: Relevance
“…Intracellular movement along microtubules mediated by interactions between microtubule motors, such as kinesins, and cargo is an important transport mechanism (Hirokawa, 1998;Miki et al, 2005). Kif17 regulates the dynamics and organization of microtubules by interacting with EB1 at microtubule plus ends and thereby promotes epithelial differentiation (Acharya et al, 2013). However, Kif17 tended to accumulate at the spindle pole (microtubule minus ends) in oocytes and this was controlled by Rab23, which interacted with Kif17.…”
Section: Discussionmentioning
confidence: 99%
“…Intracellular movement along microtubules mediated by interactions between microtubule motors, such as kinesins, and cargo is an important transport mechanism (Hirokawa, 1998;Miki et al, 2005). Kif17 regulates the dynamics and organization of microtubules by interacting with EB1 at microtubule plus ends and thereby promotes epithelial differentiation (Acharya et al, 2013). However, Kif17 tended to accumulate at the spindle pole (microtubule minus ends) in oocytes and this was controlled by Rab23, which interacted with Kif17.…”
Section: Discussionmentioning
confidence: 99%
“…When KIF17 is depleted from these cells, they fail to form a single lumen and apical markers GP135 and GP114 remain randomly localized on the plasma membrane. KIF17 depletion and overexpression experiments in 2D cultures revealed that KIF17 attenuates MT dynamics, stabilizes MTs, induces cortical MTand actin remodeling by activating RhoA locally, and stabilizes E-cadherin at AJ (Acharya et al 2013(Acharya et al , 2016Jaulin and Kreitzer 2010). Despite the similar failure of KIF3A-and KIF17-depleted cells to position apical membrane markers and form apical lumens, differences in how these kinesins affect MTs suggest they do not act by entirely equivalent mechanisms.…”
Section: Microtubule Motor Proteins and Lumen Formationmentioning
confidence: 99%
“…In contrast, a truncated, constitutively active kinesin-1 accumulates in the neurite that becomes an axon and may play a role in axon specification (Jacobson et al 2006). In cultured epithelial cells, kinesin-2 family motors KIF3A/B and KIF17 contribute to regulation of MT dynamics and stabilization, to cytoskeletal remodeling, and to positioning sites of apical membrane insertion and lumen formation (Jaulin and Kreitzer 2010;Acharya et al 2013Acharya et al , 2016Boehlke et al 2013;Li et al 2014a). Both motors localize to MT plus ends and regulate MT plusend dynamics, but appear to affect epithelial polarity by distinct mechanisms, as highlighted below.…”
Section: Microtubule Motors In Initiation Of Epithelial Polarizationmentioning
confidence: 99%
See 1 more Smart Citation
“…KIF17 constructs used for this study were amplified by PCR from human A549 or Caco2 cells and cloned into Gateway expression vectors (Invitrogen) as recommended by the manufacturer and as described previously (Jaulin and Kreitzer, 2010;Acharya et al, 2013). Myc-C3, GFP-RhoA WT, myc-RhoA V14 , and myc-RhoA N19 were generous gifts from Dr Alan Hall (Memorial Sloan Kettering Cancer Center, NY, USA).…”
Section: Expression Constructsmentioning
confidence: 99%